相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment innovations for metastatic breast cancer: Nanopartiele albumin-bound (NAB) technology targeted to tumors
Ana Lluch et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
Carsten F. Gotfredsen et al.
DIABETES (2014)
Safety and efficacy evaluation of albumin-bound paclitaxel
Sara Cecco et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?
Chunlei Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies
Kine Marita Knudsen Sand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor ( FcRn) Binding
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A clinical update of using albumin as a drug vehicle - A commentary
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
Odile E. Levy et al.
PLOS ONE (2014)
Unraveling the mysteries of serum albumin-more than just a serum protein
Angelica M. Merlot et al.
FRONTIERS IN PHYSIOLOGY (2014)
Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action
Salah-Eddin Al-Batran et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
Human serum albumin from recombinant DNA technology: Challenges and strategies
Zhen Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Human serum albumin isoforms: Genetic and molecular aspects and functional consequences
Ulrich Kragh-Hansen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Novel insights into the pleiotropic effects of human serum albumin in health and disease
Chung-Eun Ha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
NMR reveals molecular interactions and dynamics of fatty acid binding to albumin
James A. Hamilton
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Albumin-drug interaction and its clinical implication
Keishi Yamasaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Fatty acid binding to serum albumin: Molecular simulation approaches
Shin-ichi Fujiwara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Binding of transition metal ions to albumin: Sites, affinities and rates
Wojciech Bal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Orthogonal Assembly of a Designed Ankyrin Repeat Protein-Cytotoxin Conjugate with a Clickable Serum Albumin Module for Half-Life Extension
Manuel Simon et al.
BIOCONJUGATE CHEMISTRY (2013)
Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension
George K. Ehrlich et al.
BIOCONJUGATE CHEMISTRY (2013)
Insulin degludec: overview of a novel ultra long-acting basal insulin
S. C. L. Gough et al.
DIABETES OBESITY & METABOLISM (2013)
Proteins: emerging carrier for delivery of cancer therapeutics
Chetan Yewale et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?
Anne S. De Groot
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
The Immunologic Functions of the Neonatal Fc Receptor for IgG
Timo Rath et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
Leslie P. Cousens et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Isil Altintas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Eric M. Pridgen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
Michael M. Schmidt et al.
STRUCTURE (2013)
Poly-S-Nitrosated Albumin as a Safe and Effective Multifunctional Antitumor Agent: Characterization, Biochemistry and Possible Future Therapeutic Applications
Yu Ishima et al.
BIOMED RESEARCH INTERNATIONAL (2013)
THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
Johan Nilvebrant et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Challenges in Development of Nanoparticle-Based Therapeutics
Neil Desai
AAPS JOURNAL (2012)
S-Nitrosated Human Serum Albumin Dimer is not only a Novel Anti-Tumor Drug but also a Potentiator for Anti-Tumor Drugs with Augmented EPR Effects
Yu Ishima et al.
BIOCONJUGATE CHEMISTRY (2012)
Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
Mengyuan Liu et al.
BMC BIOTECHNOLOGY (2012)
RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy
Shunrong Ji et al.
CANCER BIOLOGY & THERAPY (2012)
An overview of the pharmacokinetics, efficacy and safety of liraglutide
Bruce Bode
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Impact of albumin on drug delivery - New applications on the horizon
Bakheet Elsadek et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Clinical impact of serum proteins on drug delivery
Felix Kratz et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists
Alessandro Angelini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA
Shuai Shi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Selective domain stabilization as a strategy to reduce human serum albumin-human granulocyte colony stimulating factor aggregation rate
Amanda A. Cordes et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Selective domain stabilization as a strategy to reduce fusion protein aggregation
Amanda A. Cordes et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Human serum albumin: From bench to bedside
Gabriella Fanali et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS (2012)
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
Jan Terje Andersen et al.
NATURE COMMUNICATIONS (2012)
Review of the Therapeutic Uses of Liraglutide
Gina J. Ryan et al.
CLINICAL THERAPEUTICS (2011)
Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery
Reinhard Ding et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Beware of Antibodies to Dietary Proteins in Antigen-specific Immunoassays! Falsely Positive Anticytokine Antibody Tests Due to Reactivity with Bovine Serum Albumin in Rheumatoid Arthritis (The Swedish TIRA Project)
Christopher Sjowall et al.
JOURNAL OF RHEUMATOLOGY (2011)
Efficient mucosal vaccination mediated by the neonatal Fc receptor
Lilin Ye et al.
NATURE BIOTECHNOLOGY (2011)
Adnectins: engineered target-binding protein therapeutics
D. Lipovsek
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Ligand Binding Strategies of Human Serum Albumin: How Can the Cargo be Utilized?
Ankita Varshney et al.
CHIRALITY (2010)
Lactosaminated human albumin, a hepatotropic carrier of drugs
Luigi Fiume et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Native albumin for targeted drug delivery
Elena Neumann et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Antibodies against Gluco-Oxidatively Modified Human Serum Albumin Detected in Diabetes-Associated Complications
Mohd. Wajid Ali Khan et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Mechanisms of Receptor-Mediated Endocytosis in the Renal Proximal Tubular Epithelium
Akihiko Saito et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Clinical Ramifications of the MHC Family Fc Receptor FcRn
Derry C. Roopenian et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Neonatal Fc Receptor: From Immunity to Therapeutics
Timothy T. Kuo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Cubilin Is Essential for Albumin Reabsorption in the Renal Proximal Tubule
Sabine Amsellem et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin
Yasunori Iwao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
New Strategy for the Extension of the Serum Half-Life of Antibody Fragments
Sabrina Truessel et al.
BIOCONJUGATE CHEMISTRY (2009)
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
Vinod K. Rustgi
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Albumin as a Nitric Oxide-Traffic Protein: Characterization, Biochemistry and Possible Future Therapeutic Applications
Yu Ishima et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
Jan Terje Andersen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin
Claudia A. Blindauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
Kristi Baker et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
C. Fiehn et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose Homeostasis
Laurie L. Baggio et al.
GASTROENTEROLOGY (2008)
Mutations and polymorphisms of the gene of the major human blood protein, serum albumin
Lorenzo Minchiotti et al.
HUMAN MUTATION (2008)
Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE
Cheryl A. Stoddart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
Bernard M. Tijink et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein
Paul J. Yazaki et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Lucy J. Holt et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Engineering of a femtomolar affinity binding protein to human serum albumin
Andreas Jonsson et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Changes of net charge and α-helical content affect the pharmacokinetic properties of human serum albumin
Yasunori Iwao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B
Andre Warnecke et al.
ARCHIV DER PHARMAZIE (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based model
Jonghan Kim et al.
CLINICAL IMMUNOLOGY (2007)
Improved efficacy alpha(v)beta(6)-targeted albumin conjugates by conjugation of a novel auristatin derivative
Kai Temming et al.
MOLECULAR PHARMACEUTICS (2007)
Investigation of an albumin-enriched fraction of human serum and its albuminome
Rebekah L. Gundry et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels
Kai Temming et al.
BIOCONJUGATE CHEMISTRY (2006)
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin
Allen Nguyen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Perspective - FcRn transports albumin: relevance to immunology and medicine
Clark L. Anderson et al.
TRENDS IN IMMUNOLOGY (2006)
Albumin binding to FcRn: Distinct from the FcRn-IgG interaction
C Chaudhury et al.
BIOCHEMISTRY (2006)
Naturally occurring anti-albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure
ES Pires et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Oxidation of Arg-410 promotes the elimination of human serum albumin
Yasunori Iwao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene
MA Wani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Summary of recombinant human serum albumin development
K Kobayashi
BIOLOGICALS (2006)
Insulin detemir: from concept to clinical experience
P Home et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Albumin-bound paclitaxel: a next-generation taxane
William J. Gradishar
EXPERT OPINION ON PHARMACOTHERAPY (2006)
The extraordinary ligand binding properties of human serum albumin
M Fasano et al.
IUBMB LIFE (2005)
O2 and CO binding properties of artificial hemoproteins formed by complexing iron protoporphyrin IX with human serum albumin mutants
T Komatsu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Structural basis of the drug-binding specificity of human serum albumin
J Ghuman et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
RA Cardone et al.
NATURE REVIEWS CANCER (2005)
Synthesis and evaluation of insulin-human serum albumin conjugates
K Thibaudeau et al.
BIOCONJUGATE CHEMISTRY (2005)
Phase I comparability of recombinant human albumin and human serum albumin
D Bosse et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Role of Tyr84 in controlling the reactivity of Cys34 of human albumin
AJ Stewart et al.
FEBS JOURNAL (2005)
Kringle 5 peptide-albumin conjugates with anti-migratory activity
R Léger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog
R Léger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
K Nakajou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo
K Zobel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Development and characterization of a glucagon-like peptide 1-albumin conjugate -: The ability to activate the glucagon-like peptide 1 receptor in vivo
JG Kim et al.
DIABETES (2003)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Paclitaxel and its formulations
AK Singla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin
AA Bhattacharya et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Modulation of clearance of recombinant serum albumin by either glycosylation or truncation
WP Sheffield et al.
THROMBOSIS RESEARCH (2000)
Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor
AP West et al.
BIOCHEMISTRY (2000)
Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration
DL Holmes et al.
BIOCONJUGATE CHEMISTRY (2000)
Conformational transitions of the three recombinant domains of human serum albumin depending on pH
M Dockal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
